.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Citi
Cantor Fitzgerald
Deloitte
Teva
Baxter
Fish and Richardson
Federal Trade Commission
McKesson
US Army

Generated: December 16, 2017

DrugPatentWatch Database Preview

New River Company Profile

« Back to Dashboard

What is the competitive landscape for NEW RIVER, and what generic and branded alternatives to NEW RIVER drugs are available?

NEW RIVER has three approved drugs.



Summary for New River

US Patents:0
Tradenames:7
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
New RiverTRIAVIL 2-10amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverTRIAVIL 2-25amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverPROFERDEXiron dextranINJECTABLE;INJECTION017807-001Approved Prior to Jan 1, 1982BPRXNoNo► Subscribe► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-007Apr 13, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverTRIAVIL 4-10amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverTRIAVIL 4-25amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for New River

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New RiverTRIAVIL 4-10amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverTRIAVIL 4-25amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverTRIAVIL 4-50amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverTRIAVIL 2-25amitriptyline hydrochloride; perphenazineTABLET;ORAL014715-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New RiverDOXEPIN HYDROCHLORIDEdoxepin hydrochlorideCAPSULE;ORAL016987-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
McKinsey
Queensland Health
Merck
Daiichi Sankyo
Covington
Dow
Argus Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot